Author

Tao Zhou

ORCID 0000-0002-0995-325XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Tao Zhou3 papers · Chengdu University of Traditional Chinese Medicine

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Changgui Yang· 2 shared Chenghong Xiao· 2 shared Jinqiang ZhangiD· 2 shared Saini Yi· 2 shared Weike JiangiD· 2 shared Yahui LiiD· 2 shared Chan LiuiD· 1 shared Chan LiuiD· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Changgui Yang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Asperosaponin VI inhibits LPS-induced inflammatory response by activating PPAR-gamma pathway in primary microglia

Jinqiang Zhang, Saini Yi, Chenghong Xiao, Yahui Li, Chan Liu, Weike Jiang, Changgui Yang, Tao Zhou

This study shows that asperosaponin VI reduces LPS-induced inflammation in microglia by activating the PPAR-gamma pathway.

Saudi Journal of Biological Sciences · Jul 13, 2020Peer-reviewedNeuroscience

The antidepressant effects of asperosaponin VI are mediated by the suppression of microglial activation and reduction of TLR4/NF-kB induced IDO expression

Jinqiang Zhang, Saini Yi, Yahui Li, Chenghong Xiao, Chan Liu, Weike Jiang, Changgui Yang, Tao Zhou

This study shows that asperosaponin VI reduces depressive-like behaviors in LPS-treated mice by suppressing microglial activation and the TLR4/NF-κB-induced IDO pathway.

Psychopharmacology · Jun 2, 2020Peer-reviewedNeuroscience